In this video interview, Kent Thoelke, CEO of Paradigm Health, outlines why anti-kickback guidance and modern EHR-integrated ...

In today’s ACT Brief, we examine how legacy workflows pull community clinics away from patient care, why medical writing ...

Medical writing capacity pressure is fundamentally a talent development problem, not a technology problem, since hybrid ...

In this video interview, Kent Thoelke, CEO of Paradigm Health, describes how manual eligibility screening and swivel-chair ...

In today’s ACT Brief, we examine how cost barriers and site infrastructure limit participation in community trials, why ...

In this video interview, Kent Thoelke, CEO of Paradigm Health, explains why patient cost barriers and site infrastructure ...

Patients don’t experience primary endpoints, so trials that stop at biomarkers and rigid rating scales risk declaring success ...

Kurt Mussina, CEO, Paradigm Clinical Research, describes his organization’s nine locations not as separately managed sites, ...

In this video interview, Rajneesh Patil, global head of AI, digital, and innovation in clinical development at Syneos Health, explains why the shift from narrow AI tools to a continuous learning ...

Applied Clinical Trials is the thought leader in pharmaceutical drug development operations and clinical trial design, management, and monitoring.

Regulation is not preventing continuous decision readiness. Increasingly, it is defining the conditions under which it can be ...

Kurt Mussina, CEO, Paradigm Clinical Research, acknowledges that scale matters but pushes back on the idea that it should ...